The Psychosomatic Assessment

Strategies to Improve Clinical Practice

Editor(s): Fava G.A. (Bologna) 
Sonino N. (Padova) 
Wise T.N. (Falls Church, Va.) 
Table of Contents
Vol. 32, 2012
Section title: Paper
Fava GA, Sonino N, Wise TN (eds): The Psychosomatic Assessment. Strategies to Improve Clinical Practice. Adv Psychosom Med. Basel, Karger, 2012, vol 32, pp 160–181

Illness Behavior

Sirri L. · Grandi S.
Laboratory of Psychosomatics and Clinimetrics, Department of Psychology, University of Bologna, Bologna, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The term illness behavior was introduced by Mechanic and Volkart to describe the individuals’ different ways to respond to their own health status. Pilowsky’s concept of abnormal illness behavior encompasses several clinical conditions characterized by a maladaptive mode of experiencing, perceiving, evaluating and responding to one’s own health status. The concept of somatization was criticized because it implies the presence of psychological distress or an underlying psychiatric disturbance when an organic cause for somatic symptoms is not found. Thus, more atheoretical terms , such as functional somatic symptoms and medically unexplained symptoms, were introduced. Both Kellner’s Symptom Questionnaire and Derogatis’ Symptom Checklist-90 include a scale for somatic symptoms, and other questionnaires were specifically designed to measure their frequency and severity. Kellner’s Illness Attitude Scales appear to be the gold standard for the measurement of the hypochondriacal spectrum, which includes several clinical conditions, such as nosophobia, thanatophobia and health anxiety. The assessment of illnessdenial should consider that a certain degree of denial may sometimes prevent patients from overwhelming psychological distress resulting from life-threatening or stigmatized diseases. Denial may concern both physical and psychiatric symptoms. Specific instruments are available for both types of denial. The cognitive and emotional representations developed by subjects when they have to cope with an illness or a perceived health threat are subsumed under the concept of illness perception and may be assessed by the Brief Illness Perception Questionnaire.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Sigerist H: The special position of the sick. (eds) Roemer MI, Henry E: Sigerist on the Sociology of Medicine. New York, MD Publications, 1929;9-22
  2. Parsons T: The Social System. Glencoe, The Free Press 1951;
  3. Susser MW, Watson WB: Sociology in Medicine. London, Oxford University Press 1971;
  4. Susser M: Disease, illness, sickness; impairment, disability and handicap. Psychol Med 1990;20:471-473
  5. Mechanic D, Volkart EH: Illness behavior and medical diagnoses. J Health Hum Behav 1960;1:86-94
  6. Pilowsky I: Abnormal Illness Behaviour. Chichester, Wiley 1997;
  7. Pilowsky I: Abnormal illness behaviour. Br J Med Psychol 1969;42:347-351
  8. Pilowsky I: Abnormal illness behaviour (dysnosog-nosia). Psychother Psychosom 1986;46:76-84
  9. American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders. Fourth Edition Text Revision (DSM-IV-TR). Washington, American Psychiatric Association, 2000;
  10. World Health OrganizationInternational Statistical Classification of Diseases and Related Health Problems. Tenth Edition (ICD-10) Geneva, World Health Organization, 1992;
  11. Pilowsky I, Spence ND: Patterns of illness behaviour in patients with intractable pain. J Psychosom Res 1975;19:279-287
  12. Steckel W: The Interpretation of Dreams. New York, Liveright 1943;
  13. Nemiah JC: Conversion: fact or chimera. Int J Psychiatry Med 1974;5:443-448
  14. Taylor GJ: Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom 2010;79:339-349
  15. Alexander F, French TM: Studies in Psychosomatic Medicine. New York, Ronald Press 1948;
  16. Kissen DM: The significance of syndrome shift and late syndrome association in psychosomatic medicine. J Nerv Ment Dis 1963;136:34-42
  17. Engel GL: The concept of psychosomatic disorder. J Psychosom Res 1967;11:3-9
  18. Engel GL: From biomedical to biopsychosocial. 1. Being scientific in the human domain. Psychother Psychosom 1997;66:57-62
  19. Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009;78:333-341
  20. Fava GA, Sonino N: Psychosomatic medicine: a name to keep. Psychother Psychosom 2010;79:1-3
  21. Wise TN: Psychosomatic medicine: an approach needed now more than ever. Int J Clin Pract 2010;64:997-1008
  22. Fava GA, Sonino N: Psychosomatic medicine. Int J Clin Pract 2010;64:1155-1161
  23. Fava GA, Sonino N: The biopsychosocial model thirty years later. Psychother Psychosom 2008;77:1-2
  24. Lipowski ZJ: Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom 1987;47:160-167
  25. Lipowski ZJ: Somatization: the concept and its clinical application. Am J Psychiatry 1988;145:1358-1368
  26. de Jonge P, Ormel J, van den Brink RH, van Melle JP, Spijkerman TA, Kuijper A, van Veldhuisen DJ, van den Berg MP, Honig A, Crijns HJ, Schene AH: Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006;163:138-144
  27. Linke SE, Rutledge T, Johnson BD, Vaccarino V, Bittner V, Cornell CE, Eteiba W, Sheps DS, Krantz DS, Parashar S, Bairey Merz CN: Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 2009;66:499-507
  28. Schiffer AA, Pelle AJ, Smith OR, Widdershoven JW, Hendriks EH, Pedersen SS: Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. J Clin Psychiatry 2009;70:1667-1673
  29. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS: The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009;2:328-337
  30. Hoen PW, Conradi HJ, Denollet J, Martens EJ, de Jonge P: Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis. Psychother Psychosom 2010;79:319-320
  31. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J: Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010;40:807-814
  32. Bridges KW, Goldberg DP: Somatic presentation of DSM III psychiatric disorders in primary care. J Psychosom Res 1985;29:563-569
  33. Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, Wittchen HU: Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 2007;76:354-360
  34. Huijbregts KM, van Marwijk HW, de Jong FJ, Schreuders B, Beekman AT, van der Feltz-Cornelis CM: Adverse effects of multiple physical symptoms on the course of depressive and anxiety symptoms in primary care. Psychother Psychosom 2010;79:389-391
  35. Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994;61:4-24
  36. Kellner R: Somatization. Theories and research. J Nerv Ment Dis 1990;178:150-160
  37. Schulte IE, Petermann F, Noeker M: Functional abdominal pain in childhood: from etiology to maladaptation. Psychother Psychosom 2010;79:73-86
  38. Balon R: Cognitive-behavioral therapy, psychotherapy and psychosocial interventions in the medically ill. Psychother Psychosom 2009;78:261-264
  39. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1-8
  40. Mayou R: Somatization. Psychother Psychosom 1993;59:69-83
  41. Kellner R: A symptom questionnaire. J Clin Psychiatry 1987;48:268-274
  42. Derogatis LR: SCL-90-R: Administration, Scoring, and Procedures Manual. ed 3.Minneapolis, National Computer Systems 1994;
  43. Fava GA, Kellner R, Lisansky J, Park S, Perini GI, Zielezny M: Rating depression in normals and depressives: observer versus self-rating scales. J Affect Disord 1986;11:29-33
  44. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L: The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15
  45. Kennedy BL, Morris RL, Pedley LL, Schwab JJ: The ability of the Symptom Checklist SCL-90 to differentiate various anxiety and depressive disorders. Psychiatr Q 2001;72:277-288
  46. Mumford DB, Bavington JT, Bhatnagar KS, Hussain Y, Mirza S, Naraghi MM: The Bradford Somatic Inventory. A multi-ethnic inventory of somatic symptoms reported by anxious and depressed patients in Britain and the Indo-Pakistan subcontinent. Br J Psychiatry 1991;158:379-386
  47. Rief W, Hiller W, Geissner E, Fichter MM: A two-year follow-up study of patients with somatoform disorders. Psychosomatics 1995;36:376-386
  48. Rief W, Hiller W: A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics 2003;44:492-498
  49. Noyes R, Langbehn DR, Happel RL, Sieren LR, Muller BA: Health Attitude Survey. A scale for assessing somatizing patients. Psychosomatics 1999;40:470-478
  50. Kroenke K, Spitzer RL, Williams JBW: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-266
  51. Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744
  52. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-1756
  53. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
  54. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
  55. Bech P: Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton. Psychother Psychosom 2009;78:202-211
  56. Sirri L, Fabbri S, Fava GA, Sonino N: New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess 2007;89:216-228
  57. Fava GA, Grandi S: Differential diagnosis of hypochondriacal fears and beliefs. Psychother Psychosom 1991;55:114-119
  58. Fava GA, Grandi S, Saviotti FM, Conti S: Hypochondriasis with panic attacks. Psychosomatics 1990;31:351-353
  59. Kellner R, Abbott P, Winslow WW, Pathak D: Fears, beliefs, and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis 1987;175:20-25
  60. Sirri L, Grandi S, Fava GA: The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom 2008;77:337-350
  61. Weck F, Bleichhardt G, Hiller W: Screening for hypochondriasis with the Illness Attitude Scales. J Pers Assess 2010;92:260-268
  62. Pilowsky I: Dimensions of hypochondriasis. Br J Psychiatry 1967;113:89-93
  63. Fink P, Ewald H, Jensen J, Sørensen L, Engberg M, Holm M, Munk-Jørgensen P: Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res 1999;46:261-273
  64. Conradt M, Cavanagh M, Franklin J, Rief W: Dimensionality of the Whiteley Index: assessment of hypochondriasis in an Australian sample of primary care patients. J Psychosom Res 2006;60:137-143
  65. Barsky AJ, Wyshak G, Klerman GL: The Somatosensory Amplification Scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24:323-334
  66. Barsky AJ, Wyshak G: Hypochondriasis and related health attitudes. Psychosomatics 1989;30:412-420
  67. Barsky AJ, Goodson JD, Lane RS, Cleary PD: The amplification of somatic symptoms. Psychosom Med 1988;50:510-519
  68. Lucock MP, Morely S: The Health Anxiety Questionnaire. Br J Health Psychol 1996;1:137-150
  69. Rief W, Hiller W, Margraf J: Cognitive aspects of hypochondriasis and the somatization syndrome. J Abnorm Psychol 1998;107:587-595
  70. Warwick HM, Salkovskis PM: Cognitive and behavioural characteristics of primary hypochondriasis. Scand J Behav Ther 1989;18:85-92
  71. Warwick HMC, Salkovskis PM: Hypochondriasis. Behav Res Ther 1990;28:105-117
  72. Salkovskis PM, Rimes KA, Warwick HMC, Clark DM: The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002;32:843-853
  73. Longley SL, Watson D, Noyes R: Assessment of the hypochondriasis domain: the Multidimensional Inventory of Hypochondriacal Traits (MIHT). Psychol Assess 2005;17:3-14
  74. Bianchi GN: Origins of disease phobia. Aust N Zeal J Psychiatry 1971;5:241-257
  75. Ryle JA: Nosophobia. Br J Psychiatry 1948;94:1-17
  76. Ross MW: AIDS phobia: report of 4 cases. Psychopathology 1988;21:26-30
  77. Brown RS, Lees-Haley PR: Fear of future illness, chemical AIDS, and cancerphobia: a review. Psychol Rep 1992;71:187-207
  78. Eifert GH: Cardiophobia: a paradigmatic behavioural model of heart-focused anxiety and nonanginal chest pain. Behav Res Ther 1992;30:329-345
  79. McEvedy CJ, Basquille J: BSE, public anxiety and private neurosis. J Psychosom Res 1997;42:485-486
  80. Noyes R, Carney CP, Langbehn DR: Specific phobia of illness: search for a new subtype. J Anxiety Disord 2004;18:531-545
  81. Warwick HMC, Marks IM: Behavioral treatment of illness phobia and hypochondriasis. Br J Psychiatry 1988;152:239-241
  82. Logsdail S, Lovell K, Warwick H, Marks I: Behavioural treatment of AIDS-focused illness phobia. Br J Psychiatry 1991;159:422-425
  83. Bouman TK, Visser S: Cognitive and behavioural treatment of hypochondriasis. Psychother Psychosom 1998;67:214-221
  84. Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M: Explanatory therapy in hypochondriasis. J Clin Psychiatry 2000;61:317-322
  85. Ryle JA: Angor animi, or the sense of dying. Guy's Hospital Reports 1928;78:230-235
  86. Ryle JA: The sense of dying. A Postscript. Guy's Hospital Reports 1949;99:224-225
  87. Morselli E: Sulla dismorfofobia e sulla tafefobia. Boll Reale Accad Med Genova 1891;6:5-14
  88. Kellner R: Somatization and Hypochondriasis. New York, Praeger Publishers 1986;
  89. Bartolucci G, Savron G, Fava GA, Grandi S, Trombini G, Orlandi C: Psychological reactions to thermography and mammography. Stress Med 1989;5:195-199
  90. Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom 2005;74:100-107
  91. Babinski MJ: Contribution a l'étude des troubles mentaux dans l'hémiplégie organique cérébrale (anosognosie). Revue Neurol 1914;12:845-848
  92. McGlynn SM, Schacter DL: Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol 1989;11:143-205
  93. Freud A: The Ego and the Mechanisms of Defense. London, Hogarth 1961;
  94. Lazarus RS: The costs and benefits of denial. (eds) Breznitz S: The Denial of Stress. New York, International Universities Press, 1983;3-30
  95. Kreitler S: Denial in cancer patients. Cancer Invest 1999;17:514-534
  96. Rifkin A: Is it denial or wisdom to accept life threatening illness?. BMJ 2001;323:1071
  97. Levine J, Warrenburg S, Kerns R, Schwartz G, Delaney R, Fontana A, Gradman A, Smith S, Allen S, Cascione R: The role of denial in recovery from coronary heart disease. Psychosom Med 1987;49:109-117
  98. Goldbeck R: Denial in physical illness. J Psychosom Res 1997;43:575-593
  99. Kunkel EJ, Woods CM, Rodgers C, Myers RE: Consultations for ‘maladaptive denial of illness’ in patients with cancer: psychiatric disorders that result in noncompliance. Psychooncology 1997;6:139-149
  100. Moyer A, Levine EG: Clarification of the conceptualization and measurement of denial in psychosocial oncology research. Ann Behav Med 1998;20:149-160
  101. Fowers BJ: The cardiac denial of impact scale: a brief, self-report research measure. J Psychosom Res 1992;36:469-475
  102. Robinson KR: Developing a scale to measure denial levels of clients with actual or potential myocardial infarctions. Heart Lung 1994;23:36-44
  103. Goldsmith RJ, Green BL: A rating scale for alcoholic denial. J Nerv Ment Dis 1988;176:614-620
  104. Hackett TP, Cassem NH: Development of a quantitative rating scale to assess denial. J Psychosom Res 1974;18:93-100
  105. Havik OE, Maeland JG: Dimensions of verbal denial in myocardial infarction: correlates to 3 denial scales. Scand J Psychol 1986;27:326-339
  106. Strauss DH, Spitzer RL, Muskin PR: Maladaptive denial of physical illness: a proposal for DSM-IV. Am J Psychiatry 1990;147:1168-1172
  107. Muskin PR, Feldhammer T, Gelfand JL, Strauss DH: Maladaptive denial of physical illness: a useful new ‘diagnosis’. Int J Psychiatry Med 1998;28:463-477
  108. Fava GA, Wise TN: Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders. Am J Psychiatry 2007;164:1002-1003
  109. Wise TN: Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom 2009;78:330-332
  110. Amador XF, Strauss DH: Poor insight in schizophrenia. Psychiatr Q 1993;64:305-318
  111. Mintz AR, Dobson KS, Romney DM: Insight in schizophrenia: a meta-analysis. Schizophr Res 2003;61:75-88
  112. Schwartz RC, Cohen BN, Grubaugh A: Does insight affect long-term inpatient treatment outcome in chronic schizophrenia?. Compr Psychiatry 1997;38:283-288
  113. Bartkó G, Herczeg I, Zádor G: Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatr Scand 1988;77:74-76
  114. Kelly BD, Clarke M, Browne S, McTigue O, Kamali M, Gervin M, Kinsella A, Lane A, Larkin C, O'Callaghan E: Clinical predictors of admission status in first episode schizophrenia. Eur Psychiatry 2004;19:67-71
  115. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM: Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994;51:826-836
  116. Moore O, Cassidy E, Carr A, O'Callaghan E: Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur Psychiatry 1999;14:264-269
  117. Carroll A, Fattah S, Clyde Z, Coffey I, Owens DGC, Johnstone EC: Correlates of insight and insight change in schizophrenia. Schizophr Res 1999;35:247-253
  118. Lysaker PH, Salyers MP: Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatr Scand 2007;116:290-298
  119. Gonzalez VM: Recognition of mental illness and suicidality among individuals with serious mental illness. J Nerv Ment Dis 2008;196:727-734
  120. Barrett EA, Sundet K, Faerden A, Agartz I, Bratlien U, Romm KL, Mork E, Rossberg JI, Steen NE, Andreassen OA, Melle I: Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis. Schizophr Res 2010;123:257-262
  121. Lysaker PH, Roe D, Yanos PT: Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull 2007;33:192-199
  122. Sanz M, Constable G, Lopez-Ibor I, Kemp R, David AS: A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med 1998;28:437-446
  123. Cooke MA, Peters ER, Kuipers E, Kumari V: Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatr Scand 2005;112:4-17
  124. McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, Geller JL, Roth L: Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis 1989;177:43-47
  125. David A, Buchanan A, Reed A, Almeida O: The assessment of insight in psychosis. Br J Psychiatry 1992;161:599-602
  126. Kemp RA, David AS: Insight and compliance. (eds) Blackwell B: Compliance and the Treatment Alliance in Serious Mental Illness. Newark, Gordon & Breach, 1996;61-84
  127. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM: Assessment of insight in psychosis. Am J Psychiatry 1993;150:873-879
  128. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
  129. Marková IS, Berrios GE: The assessment of insight in clinical psychiatry: a new scale. Acta Psychiatr Scand 1992;86:159-164
  130. Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M: A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand 1994;89:62-67
  131. Beck AT, Baruch E, Balter JM, Steer RA, Warman DM: A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res 2004;68:319-329
  132. Marková IS, Roberts KH, Gallagher C, Boos H, McKenna PJ, Berrios GE: Assessment of insight in psychosis: a re-standardization of a new scale. Psychiatry Res 2003;119:81-88
  133. Leventhal H, Nerenz DR, Steele DS: Illness representations and coping with health threats. (eds) Baum A, Singer JE: Handbook of Psychology and Health. New York, Erlbaum, 1984;221-252
  134. Lau RR, Hartman KA: Common sense representations of common illnesses. Health Psychol 1983;2:167-185
  135. Anagnostopoulos F, Spanea E: Assessing illness representations of breast cancer: a comparison of patients with healthy and benign controls. J Psychosom Res 2005;58:327-334
  136. Weinman J, Petrie KJ, Moss-Morris R, Horne R: The Illness Perception Questionnaire: a new method for assessing illness perceptions. Psychol Health 1996;11:431-446
  137. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D: The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002;17:1-16
  138. Broadbent E, Petrie KJ, Main J, Weinman J: The Brief Illness Perception Questionnaire. J Psychosom Res 2006;60:631-637
  139. Petrie KJ, Jago LA, Devcich DA: The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry 2007;20:163-167
  140. French DP, Cooper A, Weinman J: Illness perceptions predict attendance at cardiac rehabilitation following acute myocardial infarction: a systematic review with meta-analysis. J Psychosom Res 2006;61:757-767

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50